MEI Pharma, Inc. 是一家从事药品化合物开发的制药公司。公司总部位于美国加利福尼亚州圣地亚哥,目前拥有28名全职员工。该公司于2003年12月18日上市。该公司的资金管理计划以莱特币为依托。公司已终止Voruciclib的临床开发,但与候选药物资产相关的某些非临床活动仍在继续进行。在评估战略选择的过程中,公司可能会考虑现有项目的对外许可机会以及并购机会。
MEIP stock price ended at $0 on 星期六, after dropping NaN%
On the latest trading day May 30, 2026, the stock price of MEIP fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for MEIP decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.